Published date: 18 March 2024
Last edited date: 19 April 2024
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£540,000,000
Procurement reference
CF-2244700D0O000000rwimUAA
Published date
18 March 2024
Closing date
23 April 2024
Closing time
1pm
Contract start date
1 November 2024
Contract end date
31 October 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024
Offer reference number: CM/PHS/24/5709
Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.
More information
Previous notice about this procurement
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 November 2024
- Opportunity
- Published 18 March 2024
Attachments
-
- Document No. 02 - Terms of Offer _Final_.docx
- Document No. 02 - Terms of Offer _Final_
-
- Document No. 05b - Offer Schedule Quotation Tool.xlsx
- Document No. 05b - Offer Schedule Quotation Tool
-
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements 5709.docx
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements 5709
-
- Document No. 06 - Form of offer 5709.doc
- Document No. 06 - Form of offer 5709
-
- Document No. 08 - Confidential Undertaking 5709.docx
- Document No. 08 - Confidential Undertaking 5709
-
- Document No. 04a - Quality Assurance Process 5709.doc
- Document No. 04a - Quality Assurance Process 5709
-
- Appendix A - PrEP & PEP Account Details.xlsx
- Appendix A - PrEP & PEP Account Details
-
- Document No. 05c- Prevent, Test, Treat and Retain Initiatives Template 5709.docx
- Document No. 05c- Prevent, Test, Treat and Retain Initiatives Template 5709
-
- Document No. 03 - Framework Agreement and Terms and Conditions 5709.docx
- Document No. 03 - Framework Agreement and Terms and Conditions 5709
-
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).pdf
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)
-
- Document No. 05a - Offer Schedule Additional Information.xlsx
- Document No. 05a - Offer Schedule Additional Information
-
- Document No. 07a - Quality control technical sheet - CM_PHS_24_5709.doc
- Document No. 07a - Quality control technical sheet - CM_PHS_24_5709
-
- Document No. 01 - Invitation to offer covering letter 5709.docx
- Document No. 01 - Invitation to offer covering letter 5709
Additional text
-
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
About the buyer
Contact name
Collette Patrick
Address
Rutland House
Runcorn
WA7 2ES
United Kingdom
Share this notice
Closing: 23 April 2024, 1pm